What bluebird bio, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Cloonan Michael | Director | Jun 02 | Disposition to Issuer · D | −1,867 | — | — | 0 |
| Leiderman Elisabeth | Director | Jun 02 | Disposition to Issuer · D | −1,245 | — | — | 0 |
| Agwunobi John O | Director | Jun 02 | Disposition to Issuer · D | −1,245 | — | — | 0 |
| Paulson Richard A. | Director | Jun 02 | Disposition to Issuer · D | −1,323 | — | — | 0 |
| Leschly Nick | Director | Jun 02 | Disposition to Issuer · D | −1,245 | — | — | 0 |
| Sterling O. James | Chief Financial Officer | Jun 02 | Disposition to Issuer · D | −2,500 | — | — | 0 |
| Sterling O. James | Chief Financial Officer | Jun 02 | Disposition to Issuer · D | −5,000 | — | — | 0 |
| Klima Thomas J | See Remarks | Jun 02 | Disposition to Issuer · D | −2,500 | — | — | 0 |
| Klima Thomas J | See Remarks | Jun 02 | Grant / award · A | +2,500 | — | — | 2,500 |
| Klima Thomas J | See Remarks | Jun 02 | Disposition to Issuer · D | −4,464 | — | — | 0 |
| Jones-Burton Charlotte | Director | Jun 02 | Disposition to Issuer · D | −1,245 | — | — | 0 |
| Obenshain Andrew | President and CEO | Jun 02 | Disposition to Issuer · D | −14,820 | — | — | 0 |
| Obenshain Andrew | President and CEO | Jun 02 | Grant / award · A | +14,820 | — | — | 14,820 |
| Obenshain Andrew | President and CEO | Jun 02 | Disposition to Issuer · D | −9,300 | — | — | 0 |
| Vachon Mark | Director | Jun 02 | Disposition to Issuer · D | −1,245 | — | — | 0 |
| Tita-Reid Najoh | Director | Jun 02 | Disposition to Issuer · D | −1,245 | — | — | 0 |
| Colvin Richard A | Chief Medical Officer | Jun 02 | Disposition to Issuer · D | −2,500 | — | — | 0 |
| Colvin Richard A | Chief Medical Officer | Jun 02 | Grant / award · A | +2,500 | — | — | 2,500 |
| Colvin Richard A | Chief Medical Officer | Jun 02 | Disposition to Issuer · D | −4,166 | — | — | 0 |
| Sterling O. James | Chief Financial Officer | Jun 02 | Grant / award · A | +2,500 | — | — | 2,500 |
Loading...
